AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BIOPHARMA CREDIT PLC

Declaration of Voting Results & Voting Rights Announcements Feb 3, 2025

4973_rns_2025-02-03_eb7306c7-9d6c-4bd3-9acc-c0f898636041.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7082V

BioPharma Credit PLC

03 February 2025

BioPharma Credit plc

(the "Company")

TOTAL VOTING RIGHTS

In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies the market that the issued share capital and voting rights of the Company, as at 31 January 2025, were as follows:

Class of share Total number of shares in circulation Number of voting rights attached to each share Total number of voting rights of shares in circulation Number of shares held in treasury Total number of shares in issue
Ordinary $0.01 shares 1,180,197,249 1 1,180,197,249 193,734,818 1,373,932,067

The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in BioPharma Credit PLC under the FCA's Disclosure Guidance and Transparency Rules.

3 February 2025

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVREALADEDKSEFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.